PPL reports Phase II tgBSSL data

PPL (LSE:PTH) said that in a Phase II study of seven patients with cystic fibrosis, its transgenic Bile Salt Stimulated Lipase (tgBSSL) to treat chronic pancreatic insufficiency in CF produced a dose ...